Identification of Pacemaker Lead Position Using Fluoroscopy to Avoid Significant Tricuspid Regurgitation

Permanent pacemaker implantation improves survival but can cause tricuspid valve dysfunction in the form of tricuspid regurgitation (TR). The dominant mechanism of pacemaker-mediated TR is lead impingement. This study evaluated the association between the location of the pacemaker leads crossing the tricuspid valve and the incidence of worsening TR and lead impingement using fluoroscopy. Lead positions were evaluated using perpendicular right anterior oblique (RAO) and parallel left anterior oblique (LAO) fluoroscopic angulation views of the tricuspid annulus. A two-dimensional transthoracic echocardiogram (TTE) was performed to evaluate the maximum TR jet area-to-right atrium ratio and define regurgitation severity. A three-dimensional TTE was performed to evaluate lead impingement. A worsening of TR was observed in 23 of 82 subjects. Most leads had an inferior position in the RAO view and a septal position in the LAO view. The mid position in the RAO view and septal position in the LAO view were risk factors for lead impingement. Mid and septal positions were associated with higher risks of significant TR and lead impingement. Lead impingement was associated with a high risk of significant TR. Pacemaker-mediated TR remains a significant problem after lead implantation.

[1]  C. Hengstenberg,et al.  Pacemaker lead-associated tricuspid regurgitation in patients with or without pre-existing right ventricular dilatation , 2021, Clinical Research in Cardiology.

[2]  L. Jarahi,et al.  Effect of Right Ventricular Lead Placement on Tricuspid Valve: Added Value of Post-procedural Fluoroscopy to Three Dimensional Echocardiography in a Prospective Cohort Study , 2020 .

[3]  G. Hong,et al.  Prevalence, predictors, and prognosis of tricuspid regurgitation following permanent pacemaker implantation , 2020, PloS one.

[4]  N. Ohte,et al.  Comparison of Outcomes in Patients With Heart Failure With Versus Without Lead-Induced Tricuspid Regurgitation After Cardiac Implantable Electronic Devices Implantations. , 2020, The American journal of cardiology.

[5]  L. Fauchier,et al.  Galectin-3 predicts response and outcomes after cardiac resynchronization therapy , 2018, Journal of Translational Medicine.

[6]  Jeroen J. Bax,et al.  Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history , 2018, European heart journal.

[7]  K. Ellenbogen,et al.  Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads , 2018, Pacing and clinical electrophysiology : PACE.

[8]  R. Machado,et al.  Classification and pathophysiology of pulmonary hypertension , 2018, Continuing Cardiology Education.

[9]  W. Manning,et al.  Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation. , 2017, Journal of the American College of Cardiology.

[10]  Yuchi Han,et al.  Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[11]  Francesca N. Delling,et al.  Tricuspid Regurgitation and Mortality in Patients With Transvenous Permanent Pacemaker Leads. , 2016, The American journal of cardiology.

[12]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.

[13]  R. Schwartz,et al.  Pathogenic structural heart changes in early tricuspid regurgitation. , 2015, The Journal of thoracic and cardiovascular surgery.

[14]  V. Jeevanandam,et al.  Impact of implantable transvenous device lead location on severity of tricuspid regurgitation. , 2014, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  V. Jeevanandam,et al.  3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. , 2014, JACC. Cardiovascular imaging.

[16]  Mark L. Greenberg,et al.  Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors , 2013, Pacing and clinical electrophysiology : PACE.

[17]  K. Chan,et al.  Prevalence and mechanism of tricuspid regurgitation following implantation of endocardial leads for pacemaker or cardioverter-defibrillator. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  S. Vittala,et al.  Predictors for the Development of Severe Tricuspid Regurgitation with Anatomically Normal Valve in Patients with Atrial Fibrillation , 2012, Echocardiography.

[19]  R. Nevzorov,et al.  Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[20]  A. Lahad,et al.  Tricuspid Incompetence Following Permanent Pacemaker Implantation , 2009, Pacing and clinical electrophysiology : PACE.

[21]  Yukio Sekiguchi,et al.  Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[22]  D. Spevack,et al.  The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  T. Sundt,et al.  Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. , 2005, Journal of the American College of Cardiology.

[24]  G. Lamas,et al.  Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. , 1998, The American journal of cardiology.

[25]  R. Siegel,et al.  Functional Tricuspid Regurgitation Caused by Chronic Atrial Fibrillation: A Real-Time 3-Dimensional Transesophageal Echocardiography Study. , 2017, Circulation. Cardiovascular imaging.